Effects of Neoadjuvant Intraperitoneal/Systemic Chemotherapy (Bidirectional Chemotherapy) for the Treatment of Patients with Peritoneal Metastasis from Gastric Cancer
Figure 2
Survivals of 82 patients who underwent CRS, and 14 patients who did not underwent CRS.